Trials / Unknown
UnknownNCT02449330
Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study
Clinical Study for the Effect of Teneligliptin on the Left Ventricular Diastolic Dysfunction in Patients With Type 2 Diabetes Mellitus
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 936 (estimated)
- Sponsor
- National Cerebral and Cardiovascular Center, Japan · Academic / Other
- Sex
- All
- Age
- 20 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
This is the clinical trial designed to assess the cardiac diastolic function of long term treatment with teneligliptin compared to that without teneligliptin in patients with type 2 diabetes mellitus by two arms; one includes patients showing E/e' by echocardiography less than 8, the other includes patients showing E/e' by echocardiography more than 8.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Teneligliptin |
Timeline
- Start date
- 2015-06-01
- Primary completion
- 2020-06-01
- Completion
- 2023-06-01
- First posted
- 2015-05-20
- Last updated
- 2018-08-22
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02449330. Inclusion in this directory is not an endorsement.